Crossmark

A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia

Crossref DOI link: https://doi.org/10.1007/s00198-014-2838-7

Published Online: 2014-08-20

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, J.F.

Yang, K. H.

Zhang, Z.L.

Chang, H.C.

Chen, Y.

Sowa, H.

Gürbüz, S.
License Information

Text and Data Mining valid from 2014-08-20

Document is current

Any future updates will be listed below